Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AMIX

Autonomix Medical Inc

Oct 30 • 04:00PM ET

1.03

-0.02 -1.90 %

Healthcare • Medical Devices • USA • NASD

Peers: ISRG BSX MDT JNJ SYK ABT EW ZBH HOLX ALGN

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.28	Insider Own	21.52%	Shs Outstand	6.19M	Perf Week	-8.04%
Market Cap	6.38M	Forward P/E	-	EPS next Y	-1.95	Insider Trans	0.00%	Shs Float	4.86M	Perf Month	-11.97%
Enterprise Value	-2.21M	PEG	-	EPS next Q	-1.10	Inst Own	4.76%	Short Float	4.36%	Perf Quarter	-25.90%
Income	-12.05M	P/S	-	EPS this Y	57.82%	Inst Trans	-7.94%	Short Ratio	0.51	Perf Half Y	-55.02%
Sales	0.00M	P/B	0.59	EPS next Y	28.44%	ROA	-149.73%	Short Interest	0.21M	Perf YTD	-72.61%
Book/sh	1.75	P/C	0.74	EPS next 5Y	32.01%	ROE	-195.55%	52W High	17.15 -93.99%	Perf Year	-91.68%
Cash/sh	1.39	P/FCF	-	EPS past 3/5Y	22.10% -	ROIC	-171.32%	52W Low	0.96 7.16%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.05% 7.23%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	65.72%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.57	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.58	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.57	EPS Q/Q	62.37%	SMA20	-8.63%	Beta	-2.68	Target Price	6.60
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-7.81%	Rel Volume	0.33	Prev Close	1.05
Employees	11	LT Debt/Eq	0.00	Earnings	Sep 03	SMA200	-40.16%	Avg Volume	415.79K	Price	1.03
IPO	Jan 29, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	137,492	Change	-1.90%

Oct-24-25 09:00AM	Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Conference (GlobeNewswire)
Oct-16-25 09:15AM	Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit (GlobeNewswire)
Oct-09-25 08:45AM	Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology (GlobeNewswire)
Oct-02-25 08:45AM	Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Sep-29-25 09:15AM	Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System (GlobeNewswire)
09:00AM	Loading…
Sep-09-25 09:00AM	Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress (GlobeNewswire)
Sep-04-25 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment (GlobeNewswire) -8.90%
07:00AM	Innovation and IP in Medtech Stocks - How Patents Build Leaders (Newsfile)
Sep-03-25 08:30AM	Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study (GlobeNewswire)
Sep-02-25 08:30AM	Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire) +10.71%
Aug-20-25 08:30AM	Autonomix Medical, Inc. Granted New European Patent for First-in-Class Catheter-Based Technology (GlobeNewswire)
Aug-18-25 09:15AM	Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc. (GlobeNewswire)
Aug-15-25 09:00AM	Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech (GlobeNewswire)
Aug-14-25 08:30AM	Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies (GlobeNewswire)
Jul-31-25 12:00PM	Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why (Zacks) +9.09%
08:45AM	Loading…
Jul-22-25 08:45AM	Autonomix Medical, Inc. Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference (GlobeNewswire) -24.04%
08:40AM	JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live (ACCESSWIRE)
08:30AM	Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds (GlobeNewswire)
Jul-21-25 08:45AM	Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications (GlobeNewswire) +15.82%
Jul-07-25 08:30AM	Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Jun-30-25 08:30AM	Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase ("PoC 2") of Proof-of-Concept Human Clinical Study (GlobeNewswire) -21.89%
Jun-27-25 08:00AM	Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology (GlobeNewswire) +60.80%
Jun-05-25 08:45AM	Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain (GlobeNewswire) -15.85%
May-22-25 11:39AM	AMIX Stock May Climb Following Key U.S. Patent for Nerve-Sensing Tech (Zacks)
May-15-25 08:30AM	Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology (GlobeNewswire) +9.20%
May-14-25 09:20AM	Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event (GlobeNewswire) -5.95%
May-13-25 09:20AM	Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market (GlobeNewswire) +5.71%
May-05-25 08:30AM	Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain (GlobeNewswire)
May-01-25 09:25AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor "What This Means" Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain (GlobeNewswire)
Apr-30-25 08:15AM	Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain (GlobeNewswire) -7.51%
08:30AM	Loading…
Apr-24-25 08:30AM	Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR (GlobeNewswire)
Apr-17-25 05:00PM	Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-16-25 08:30AM	Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology (GlobeNewswire) +5.99%
Apr-08-25 08:15AM	Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain (GlobeNewswire)
Apr-03-25 08:30AM	Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) (GlobeNewswire)
Mar-21-25 05:00PM	Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -9.13%
Mar-20-25 08:30AM	Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology (GlobeNewswire) +10.61%
Mar-14-25 08:30AM	Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation (GlobeNewswire) -9.76%
Mar-06-25 09:00AM	Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting (GlobeNewswire)
Feb-26-25 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA '25 Emerging Medtech Summit (GlobeNewswire)
Feb-20-25 08:30AM	Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting (GlobeNewswire)
Feb-19-25 09:00AM	Autonomix Medical, Inc. Participates in the Virtual Investor Top 5 for '25 On-Demand Conference (GlobeNewswire)
Feb-13-25 08:00AM	Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Jan-24-25 08:45AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Jan-17-25 08:00AM	Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025 (GlobeNewswire) +9.79%
Jan-15-25 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +10.55%
Jan-13-25 08:30AM	Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting (GlobeNewswire) -8.65%
Dec-30-24 08:30AM	Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology (GlobeNewswire) +20.61%
Dec-23-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Dec-19-24 08:30AM	Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality (GlobeNewswire) -5.06%
Dec-05-24 08:30AM	Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 (GlobeNewswire) -6.72%
Nov-25-24 04:00PM	Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option (GlobeNewswire) -5.21%
Nov-22-24 09:15AM	Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering (GlobeNewswire) -53.55%
Nov-11-24 08:00AM	Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Oct-31-24 08:00AM	Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction (GlobeNewswire) +39.75%
Oct-30-24 08:30AM	Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire)
Oct-28-24 08:00AM	Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial (GlobeNewswire) +60.57%
Oct-25-24 11:30AM	Autonomix Medical, Inc. to Participate in a Virtual Investor What This Means Segment on Wednesday, October 30th (GlobeNewswire) -22.12%
Oct-22-24 08:30AM	Autonomix Announces Reverse Stock Split (GlobeNewswire)
Oct-08-24 08:30AM	Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC (GlobeNewswire)
Oct-03-24 08:35AM	This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer (News Direct)
Sep-26-24 07:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Sep-20-24 08:30AM	Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum (GlobeNewswire)
Sep-09-24 07:00AM	Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients (GlobeNewswire) +9.09%
Aug-27-24 08:30AM	Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-21-24 08:30AM	Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress (GlobeNewswire)
Aug-13-24 08:00AM	Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones (GlobeNewswire)
Aug-02-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire) -23.30%
Jul-24-24 08:00AM	Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology (GlobeNewswire)
Jul-22-24 09:05AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +9.22%
Jul-18-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor What This Means Segment Covering Technology License Agreement (GlobeNewswire) +10.66%
Jul-16-24 08:25AM	Why Is Autonomix Medical (AMIX) Stock Down 17% Today? (InvestorPlace) -23.19%
07:43AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jul-15-24 01:48PM	Why Is Autonomix Medical (AMIX) Stock Up 120% Today? (InvestorPlace) +123.30%
01:30PM	Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer (ACCESSWIRE)
08:00AM	Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc. (GlobeNewswire)
Jul-12-24 08:45AM	Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer (News Direct) +6.55%
Jul-11-24 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform (GlobeNewswire) +7.21%
Jul-03-24 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor What This Means Segment (GlobeNewswire) -31.76%
Jun-18-24 08:00AM	Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire) -17.04%
Jun-17-24 04:05PM	Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer (GlobeNewswire) -7.53%
Jun-10-24 08:00AM	Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024 (GlobeNewswire) -9.49%
Jun-06-24 09:00AM	This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management (News Direct) -9.09%
Jun-03-24 02:52PM	AMIX Stock Earnings: Autonomix Medical Reported Results for Q4 2024 (InvestorPlace) -10.53%
08:15AM	Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire)
May-31-24 08:05AM	Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) +7.55%
May-23-24 09:15AM	Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer (GlobeNewswire) -5.91%
May-14-24 04:15PM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire)
Apr-25-24 08:30AM	Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip (GlobeNewswire) +6.84%
Apr-24-24 09:00AM	Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar (GlobeNewswire)
Apr-16-24 09:00AM	Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain (GlobeNewswire) -5.42%
Apr-15-24 12:03PM	Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology (News Direct)
Apr-11-24 08:55AM	Autonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat Diseases (News Direct)
Apr-09-24 08:30AM	Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation (GlobeNewswire)
Apr-08-24 08:30AM	Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker (GlobeNewswire)
Mar-27-24 09:00AM	Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference (GlobeNewswire)
Mar-20-24 08:05AM	Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024 (GlobeNewswire)
Mar-19-24 08:45AM	Autonomix Appoints Jennifer Cook as Chief Business Officer (GlobeNewswire)
Mar-14-24 08:15AM	Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market (GlobeNewswire) +16.33%
Mar-06-24 08:00AM	Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market (GlobeNewswire) -7.08%

Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in The Woodlands, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMIX

Autonomix Medical Inc

Upgrade your FINVIZ experience